Skip to main content
. 2020 May 28;28(7):925–937. doi: 10.1038/s41431-020-0581-4

Table 2.

Disease-causing and likely pathogenic alleles (simple and complex) in ABCA4 (NM_000350.3) and their phenotypic effect in 24 Stargardt families from an isolated population.

Family member Variants identified Age Age dx VA now VF CV defect ERG Phenotype
S1:III-4 c.[5714+5G>A];[4163T>C] 90 20 R-CF L-CF Central scotoma Mild NA Central choroidal sclerosis
S1:III-6 c.[5714+5G>A];[4163T>C] 75 45 R-CF 3 ft L-HM Central scotoma Medium NA STGD
S1:V-1 c.4577C>T(;)4163T>C NA NA NA NA NA NA NA
S2:IV-5 c.[5714+5G>A];[67-1delG] 35 17 R-20/400 L-20/400 Central scotoma Mild Rod-normal cone-slight dec CRD
S2:V-1 c.[5714+5G>A];[67-1delG] 16 14 R-20/400 L-20/400 Central scotoma Mild Rod-normal CRD
S2:V-3 c.[5714+5G>A];[67-1delG] 20 18 R-20/300 L-20/300 Central scotoma Mild Rod-dec cone-normal CRD
S3:II-1 c.4469G>A(;)6089G>A(;)5603A>T NA NA NA NA NA NA NA
S4:II-2 c.[5714+5G>A];[5714+5G>A] 56 52 R-20/60 L-20/40 Central scotoma NA Rod-slight dec cone-slight dec STGD
S4:II-3 c.[5714+5G>A];[5714+5G>A] 66 47 R-20/80 L-CF Central scotoma Severe Rod-slight dec cone-slight dec STGD
S5:II-2 c.[4163T>C];[4163T>C] NA NA NA NA NA NA NA
S5:II-4 c.[4163T>C];[4163T>C] NA NA NA NA NA NA NA
S5:III-1 c.[5714+5G>A];[4163T>C] 52 26 R-20/400 L-20/300 Central scotoma Normal Rod-dec cone-Normal Atrophic macula
S6:III-1 c.[5714+5G>A];[3322C>T] 63 23 R-CF L-CF NA Mild Rod-normal cone-normal STGD
S7:II-1 c.[5714+5G>A];[5714+5G>A] 56 26 R-20/400 L-20/200 Central scotoma Mild Rod-normal cone-normal STGD
S8:II-2 c.4577C>T(;)5603A>T NA NA NA NA NA NA NA
S9:III-1 c.[5714+5G>A];[5461-10T>C;5603A>T] 67 12 R-CF L-CF Central scotoma correct NA Rod-dec cone-dec CRD
S9:III-8 c.[5714+5G>A;2588G>C];[5714+5G>A] 46 29 R-20/60 L-20/20 Normal Normal Rod-normal cone-normal STGD
S9:IV-1 c.[5714+5G>A;2588G>C]; [5461-10T>C;5603A>T] 21 15 R-20/200 L-20/300 Central scotoma Medium NA STGD
S11:II-1 c.[2588G>C;5603A>T];[6449G>A] NA NA NA NA NA NA NA
S13:II-2 c.[2588G>C;5603A>T];[4537delC] NA NA NA NA NA NA NA
S16:II-4 c.[2564G>A];[5461-10T>C;5603A>T] 71 11 R-HM L-HM Peripheral islands only Severe NA CRD
S16:IV-2 c.[5461-10T>C;5603A>T]; [5461-10T>C;5603A>T] 38 8 R-20/400 L-20/400 Peripheral Islands only Severe Rod-dec cone-dec CRD
S16:IV-3 c.[5461-10T>C;5603A>T]; [5461-10T>C;5603A>T] 39 12 R-20/400 L-CF Mid-peripheral islands only Severe Rod-dec cone-dec CRD
S16:IV-4 c.[5714+5G>A];[5461-10T>C;5603A>T] 41 13 R-20/200 L-20/400 Central scotoma NA Rod-dec cone-normal CRD
S16:V-1 c.[5461-10T>C;5603A>T]; [5461-10T>C;5603A>T] 14 8 R-20/500 L-20/300 Central scotoma Mild Rod-dec cone-dec CRD
S17:II-2 c.[5714+5G>A];[5714+5G>A] 62 39 R-20/200 L-20/50 Central scotoma Severe Rod-dec cone-normal STGD
S17:II-3 c.[5714+5G>A];[5714+5G>A] 63 46 R-20/30 L-CF Central scotoma NA NA STGD
S17:II-8 c.[5714+5G>A];[5714+5G>A] 52 41 R-20/400 L-20/40 Central scotoma NA Rod-slight dec cone-normal STGD
S18:II-1 c.2564G>A(;)4139C>T NA NA NA NA NA NA NA
S19:II-3 c.3322C>T(;)3323G>A NA NA NA NA NA NA NA
S21:II-1 c.[4139C>T];[4139C>T] NA NA NA NA NA NA NA
S22:II-2 c.[5714+5G>A];[2564G>A] 57 14 R-20/400 L-CF Peripheral Islands Severe Rod-dec cone-dec CRD
S23:II-3 c.[5461-10T>C;5603A>T]; [5603A>T] 52 14 R-20/200 L-20/200 NA NA NA NA
S23-II-4 c.[5461-10T>C;5603A>T]; [5603A>T] 51 20 R-CF L- 20/400 NA NA NA NA
S24:II-1 c.[2564G>A;5603A>T] NA NA NA NA NA NA NA
S24:II-3 c.[2564G>A;5603A>T] NA NA NA NA NA NA NA
S25:II-2a c.4139C>T(;)5714+5G>A 36 34 R-20/20 L-20/25 Small central scotomas normal NA STGD
S26:II-1a c.4577C>T(;)5714+5G>A 32 12 R-20/50−1 L-20/40−1 Central scotoma NA Rod-slight dec cone-slight dec NA
S27:II-2 c.[5714+5G>A];[3322C>T] 50 NA R-20/80 L-20/150 Small central scotomas NA Rod-slight dec cone-normal STGD
S28:II-1a c.4163T>C(;)4469G>A NA NA NA NA NA NA NA
S29:II-2a c.5714+5G>A(;)634C>T 47 45 L-20/20 R-20/20 Normal NA NA STGD

Bold indicates recurrent founder alleles.

CF counting fingers, HM hand motion, STGD Stargardt disease, CRD cone-rod dystrophy, NA not available, dec decreased, VA visual acuity, VF visual fields, dx diagnosis, ft feet, R right, L left, CV central vision, ERG electroretinogram.

aABCA4 genetic testing performed at Asper Biogene (no phasing information available).